STOCK TITAN

PurMinds Enterprises, Inc. (Formerly Pacific Software, Inc.) Appoints Angelo Pizzuto as CFO, COO, Secretary, and Treasurer to Lead PCAOB Audit and Commercialization Phase

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

PurMinds Enterprises (OTC:PFSF), a clinical-stage neuroscience company, appointed Angelo Pizzuto as CFO, COO, Secretary and Treasurer, effective immediately, succeeding James DiPrima.

Pizzuto will lead a PCAOB audit over the next two to three months, oversee commercialization of high-value opportunities, and support capital-raising initiatives, including Regulation S and D private placements.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Experienced executive appointed as CFO, COO, Secretary and Treasurer
  • PCAOB audit targeted for completion within two to three months
  • Independent accounting firm engaged for pre-audit technical review
  • New leadership focused on commercializing operating-entity opportunities
  • Planned Regulation S and D private placements to fund milestones
  • Incoming executive has previously secured over $150M in financing

Negative

  • CFO transition may create short-term execution and continuity risk
  • Company depends on future capital-raising to fund clinical and commercial milestones
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LAS VEGAS, June 10, 2026 /PRNewswire/ - PurMinds Enterprises, Inc. (formerly Pacific Software, Inc.) (OTC: PFSF) (the "Company"), a clinical-stage neuroscience company, today announced it has appointed Angelo Pizzuto as Chief Financial Officer, Chief Operating Officer, Secretary, and Treasurer, effective immediately. He succeeds James DiPrima, who resigned to pursue other professional ventures and who will remain available in an advisory capacity during the transition to ensure continuity throughout the upcoming PCAOB audit period.

PurMinds Enterprises logo

Mr. Pizzuto's immediate mandate is to lead the Company through its PCAOB audit over the next two to three months. To ensure total transparency and audit readiness, PurMinds has engaged an independent third-party accounting firm to prepare technical accounting memos and perform a rigorous internal review of the Company's financial records prior to the formal audit commencement.

Furthermore, Mr. Pizzuto will oversee the commercialization of various high-value opportunities within the Company's operating entities and will support the CEO in strategic capital-raising initiatives, including private placements under Regulation S and Regulation D, to fund the Company's clinical and commercial milestones.

Mr. Pizzuto is an accomplished senior executive with over 20 years' experience in financial planning and analysis (FP&A), mergers and acquisitions (M&A), capital markets, and corporate governance. He has a proven track record of driving business transformations, leading successful turnarounds, and securing over $150M in financing across diverse sectors in both Canada and the U.S. For the past three years, he has been a core member of the Company's operating entity, 10763942 Canada Inc. (aka PurMinds NeuroPharma), serving as CFO and COO.

Prior to joining PurMinds NeuroPharma, Mr. Pizzuto served as Vice President of Corporate Finance & Integration at Sandbox Advertising, a full-service communication and digital marketing agency serving the healthcare, biotech, and clinical therapy sectors. Previously, he was employed as CFO and COO at Monocrete Corp., a construction aggregates business. Before that, he served as VP of Finance at Soroc Technology Inc., an Ontario-based Information and technology services company.

Mr. Pizzuto has also provided fractional CFO services in financial restructuring, capital acquisition, product launches and operational scaling and related domains, to numerous entities.

He holds a Master of Business Administration, Executive Program, from Ivey Business School, University of Western Ontario.

"We are gratified to have Angelo join the PurMinds Enterprises team," said CEO Janet Qi. "His deep familiarity with the Company's operations and his leadership through our strategic development make him uniquely qualified to lead our financial and operational strategy moving forward.

"Angelo's appointment also ensures a seamless transition as we finalize our audit, initiate our capital strategy, and move toward our next phase of corporate growth."

About PurMinds Enterprises, Inc. PurMinds is a biotech company building an integrated precision medicine ecosystem through the convergence of advanced therapeutics (with focus on neurological disorders), decentralized diagnostics, and data-driven healthcare intelligence. Central to this strategy is PurMinds' exclusive partnership with SpectroChip Global Inc.

SpectroChip has developed the world's first fingernail-sized photonic chip-based diagnostic system integrating the core functionalities of spectrophotometry, chromatography, and lateral flow immunoassays (LFIA). The full-spectrum handheld or pocket-sized spectrometer can bring hospital-grade diagnostics directly to clinics, pharmacies, community health centers, and patients' bedside. In this partnership, PurMinds is the exclusive global partner to develop and supply all rapid diagnostic kits used in the SpectroChip POCT platform. Together, PurMinds and SpectroChip are developing a decentralized POCT ecosystem that combines real-time diagnostics, longitudinal health monitoring, data-driven analytics, and personalized therapeutic pathways into a unified healthcare intelligence platform, while building a scalable, recurring-revenue infrastructure designed to support sustainable growth and long-term enterprise value.

For more information, visit www.PurMinds.com.

Forward-Looking Statements This press release contains forward-looking statements regarding the Company's audit timelines, commercialization efforts, and potential capital raises. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ. The Company undertakes no obligation to update these statements should circumstances change.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/purminds-enterprises-inc-formerly-pacific-software-inc-appoints-angelo-pizzuto-as-cfo-coo-secretary-and-treasurer-to-lead-pcaob-audit-and-commercialization-phase-302795891.html

SOURCE PurMinds Enterprises, Inc.

FAQ

What leadership change did PurMinds Enterprises (OTC:PFSF) announce on June 10, 2026?

PurMinds Enterprises appointed Angelo Pizzuto as CFO, COO, Secretary and Treasurer, replacing James DiPrima. According to PurMinds, DiPrima resigned to pursue other ventures but will remain in an advisory role during the transition to support continuity through the upcoming PCAOB audit.

What is Angelo Pizzuto’s role in the PurMinds Enterprises PCAOB audit?

Angelo Pizzuto’s immediate mandate is to lead PurMinds Enterprises through its PCAOB audit. According to PurMinds, the audit is expected over two to three months, supported by an independent firm preparing technical memos and reviewing financial records before the formal audit begins.

How will Angelo Pizzuto support capital raising for PurMinds Enterprises (PFSF)?

Angelo Pizzuto will assist the CEO with strategic capital-raising initiatives for PurMinds Enterprises. According to PurMinds, this includes private placements under Regulation S and Regulation D to fund the company’s clinical and commercial milestones across its operating entities.

What commercialization responsibilities will the new CFO/COO have at PurMinds Enterprises?

As CFO and COO, Angelo Pizzuto will oversee commercialization of high-value opportunities in PurMinds operating entities. According to PurMinds, his mandate includes driving the company’s next corporate growth phase alongside audit completion and capital strategy execution.

What experience does Angelo Pizzuto bring to PurMinds Enterprises (OTC:PFSF)?

Angelo Pizzuto brings over 20 years of FP&A, M&A, capital markets and governance experience. According to PurMinds, he has secured over $150M in financing and has served as CFO and COO of PurMinds NeuroPharma for the past three years.

Why might the CFO change at PurMinds Enterprises matter to PFSF investors?

The CFO change matters because the new executive leads the PCAOB audit and capital strategy. According to PurMinds, his role covers audit readiness, commercialization efforts and future Regulation S and D financings, all of which can influence funding and execution of corporate milestones.